Cargando…
New models for defining prostate cancer biology and patient prognosis
Autores principales: | Brundage, James, Maughan, Benjamin L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788602/ https://www.ncbi.nlm.nih.gov/pubmed/34135170 http://dx.doi.org/10.4103/aja.aja_48_21 |
Ejemplares similares
-
Invited commentary for surgery open: “Defining the feasibility of same day adrenalectomy - A prospective matched cohort study”
por: Bogdanovski, Anastasia K., et al.
Publicado: (2023) -
Speckle-type POZ protein mutations in prostate cancer: a new part of the mosaic
por: Stoehr, Robert
Publicado: (2015) -
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all
por: Maughan, Benjamin L, et al.
Publicado: (2014) -
Impact of IL-23 in prostate cancer
por: Mirlekar, Bhalchandra
Publicado: (2021) -
Separate Chinese lines for prostate cancer?
por: von Eyben, Finn Edler
Publicado: (2019)